Skip to main content
SpringerLink
Log in

In New Zealand, PHARMAC has announced a widening of funded access to the in-hospital drug rituximab

  • Media release
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. PHARMAC.Greater access to life-extending lymphoma drug. Media Release: 16 Jun 2009. Available from: URL: http://www.pharmac.govt.nz

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

In New Zealand, PHARMAC has announced a widening of funded access to the in-hospital drug rituximab. Pharmacoecon. Outcomes News 581, 10 (2009). https://doi.org/10.2165/00151234-200905810-00032

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00151234-200905810-00032

Keywords

Search

Navigation